 |
Previous Article | Next Article 
The Journal of Neuroscience, February 15, 2003, 23(4):1265
The H+-Coupled Electrogenic Lysosomal Amino Acid
Transporter LYAAT1 Localizes to the Axon and Plasma Membrane of
Hippocampal Neurons
Christopher C.
Wreden1,
Juliette
Johnson2,
Cindy
Tran1,
Rebecca P.
Seal1,
David R.
Copenhagen2,
Richard J.
Reimer1, 3, and
Robert H.
Edwards1
Departments of 1 Neurology and Physiology and
2 Ophthalmology and Physiology, and 3 Graduate
Programs in Neuroscience and Cell Biology, University of California San
Francisco School of Medicine, San Francisco, California 94143
 |
ABSTRACT |
Recent work has identified a lysosomal protein that transports
neutral amino acids (LYAAT1). We now show that LYAAT1 mediates H+ cotransport with a stoichiometry of 1 H+/1 amino acid, consistent with a role in the
active efflux of amino acids from lysosomes. In neurons, however,
LYAAT1 localizes to axonal processes as well as lysosomes. In axons
LYAAT1 fails to colocalize with synaptic markers. Rather, axonal LYAAT1
colocalizes with the exocyst, suggesting a role for membranes
expressing LYAAT1 in specifying sites for exocytosis. A protease
protection assay and measurements of intracellular pH further indicate
abundant expression at the plasma membrane, raising the possibility of physiological roles for LYAAT1 on the cell surface as well as in lysosomes.
Key words:
LYAAT1; lysosome; neutral amino acid transport; exocyst; axon; neuronal ceroid lipofuscinosis
 |
Introduction |
After endocytosis the membrane
proteins destined for degradation sort to lysosomes. Lysosomal
degradation contributes to normal protein turnover and the elimination
of damaged or misfolded proteins. It also helps to terminate signals
initiated at the plasma membrane by inactivating internalized
receptors. Within the lysosome hydrolytic enzymes break down membrane
proteins into their constituent amino acids and sugars. Defects in
these enzymes result in lysosomal storage disorders such as Tay-Sachs
disease that affect multiple organs, including the nervous system
(Gravel et al., 1995 ).
Continuing protein degradation by the lysosome requires a mechanism to
clear breakdown products. Lysosomes indeed exhibit a number of
transport activities, many of which serve to remove amino acids or
carbohydrates to the cytoplasm (Pisoni and Thoene, 1991 ; Mancini et
al., 2000 ). Similar to defects in protein breakdown, defects in export
also can produce lysosomal storage disease. Cystinosis involves
the accumulation of cystine by multiple tissues and results from
mutations in a lysosomal cystine transporter (Gahl et al., 1982 ; Town
et al., 1998 ; Kalatzis et al., 2001 ). Sialic acid storage disorders
similarly result from mutations in a lysosomal transporter for sialic
acid (Mancini et al., 1991 ; Verheijen et al., 1999 ). Both of these
efflux systems rely on H+ cotransport
driven by the outwardly directed lysosomal
H+ electrochemical gradient (Smith et al.,
1987 ; Mancini et al., 1989 ). However, the proteins responsible for most
lysosomal transport activities remain unknown.
Identified several years ago, the vesicular GABA transporter (VGAT)
defined a large family of mammalian proteins (McIntire et al., 1997 ).
VGAT itself mediates the transport of GABA into synaptic vesicles and,
like many lysosomal transport activities, relies on a
H+ electrochemical gradient. In
particular, transport by VGAT involves the exchange of
H+ for GABA (McIntire et al., 1997 ).
Closely related to VGAT, the amino acid transport systems N and A
contribute to nitrogen metabolism and the glutamine-glutamate cycle
involved in recycling glutamate and GABA for release at synapses
(Chaudhry et al., 2002b ). Consistent with its function at the plasma
membrane, the system N transporter SN1 depends on
Na+ but also mediates
H+ exchange similar to VGAT (Chaudhry et
al., 1999 ). System A transporters also reside on the plasma membrane,
depend on Na+, and have retained the
sensitivity to H+; however, they do not
have the capacity for H+ translocation
(Albers et al., 2001 ; Chaudhry et al., 2002a ). The members of this
family thus vary considerably in their ionic coupling and subcellular
location. This family also includes the lysosomal amino acid
transporter LYAAT1.
Although predominantly lysosomal in many cells, heterologous expression
of LYAAT1 confers the uptake of radiolabeled GABA and many neutral
amino acids from the extracellular medium, indicating localization to
the plasma membrane as well (Sagne et al., 2001 ). Indeed, uptake by the
cell is topologically equivalent to efflux from lysosomes. Consistent
with H+ cotransport out of the lysosome,
low pH stimulates uptake by LYAAT1 at the cell surface. We now have
extended the analysis of LYAAT1 to direct measurements of
H+ flux and charge movement. The addition
of amino acid substrates reduces the pH of cells overexpressing LYAAT1,
indicating that the protein mediates H+
flux. LYAAT1 expressed in Xenopus oocytes mediates inward
charge movement in response to substrates, and this charge movement is coupled with 1:1 stoichiometry (charge/amino acid). We also have found
that LYAAT1, which is enriched in the brain, localizes to axons as well
as the perikaryal lysosomes of neurons. Axonal LYAAT1 does not
colocalize with lysosomal or synaptic vesicle markers. Rather, it
colocalizes with subunits of the exocyst complex implicated in the
specification of sites for exocytosis. In addition, a substantial proportion of endogenous LYAAT1 in neurons resides at the cell surface,
as determined by both protease protection and the response of
intracellular pH to extracellular substrates. The transporter thus may
function at the plasma membrane as well as lysosomes in neurons and in
other cells.
 |
Materials and Methods |
Molecular cloning and in situ hybridization.
A fragment of the LYAAT1 cDNA amplified by PCR from brain cDNA was
used to screen a rat brain library. Several clones containing the
entire open reading frame were isolated, sequenced, and compared with
related sequences by using the PileUp+
program (GCG Wisconsin Package, Accelrys, San Diego, CA).
For in situ hybridization a 595 bp LYAAT1 cDNA containing
the last 26 codons of the protein-coding sequence plus 3'-UTR was
amplified by PCR and subcloned into pBluescript II KS (pBS) at the
SalI-NotI sites. In situ
hybridization was performed as described previously (Fremeau et al.,
1992 ). Briefly, fresh-frozen brains from 21-d-old rats were sectioned
at 20 µm, postfixed in 4% paraformaldehyde/PBS, UV cross-linked, and
hybridized to 35S-labeled single-stranded
RNA probes in 50% formamide for 16-18 hr at 53°C.
Transport assay. LYAAT1 was expressed in HeLa cells by using
the vaccinia virus-T7 polymerase system (Povlock and Amara, 1998 ). Briefly, HeLa cells were plated on 24-well plates at a density of
100,000 per well and infected with vaccinia virus (1 × 106 pfu in 750 µl of Optimem media).
Thirty minutes later the cells were transfected with 1 µg of DNA/1.5
µg of lipofectin (Invitrogen, San Diego, CA).
Cells transfected with empty pBS plasmid were used as controls. After
16-20 hr the cells were washed three times with Krebs-Ringer
solution, pH 7.4 [containing (in mM) 120 NaCl, 4.7 KCl,
2.2 CaCl2, 1.2 MgCl2, 1.2 KH2PO4, and 10 HEPES plus
0.18% glucose], and incubated for 5 min (or the time indicated in the text) in 250 µl of Krebs-Ringer solution, pH 5.5, containing MES buffer, 120 mM choline chloride substituted for 120 mM sodium chloride (assay buffer), and 100 µM
[2,3-3H]-proline (PerkinElmer Life
Sciences, Emeryville, CA). Then the cells were rinsed
three times with cold assay buffer, solubilized in 1% SDS for 30 min
at room temperature, and mixed with 3 ml of Ecolume (ICN
Biochemicals, Costa Mesa, CA). All measurements were made in
triplicate. To assess inhibition, we added 2 mM
competing amino acid to the standard assay mixture. To assess ionic
dependence, we used choline chloride (120 mM), choline
chloride/potassium chloride (60 mM each), sodium chloride
(120 mM), or sodium gluconate (120 mM) in both
the assay and wash buffers. For experiments that used nigericin (5 µM) and valinomycin (20 µM), choline
chloride/potassium chloride (60 mM each) was used.
Quantitation and statistics were performed by using the Prism program
(GraphPad Software, San Diego, CA).
Measurement of intracellular pH in HeLa cells. The vaccinia
virus-T7 polymerase system was used to express LYAAT1 in HeLa cells at
a density of 40,000 cells per glass coverslip coated with Matrigel
(Becton Dickinson, Mountain View, CA). The cells were
loaded for 10 min with 5 µM BCECF-AM (Molecular
Probes, Eugene, OR) in Krebs-Ringer solution, pH 7.4, and
washed for 10 min in the same buffer before the pH of individual cells
was measured by ratiometric methods at 440 and 490 nm excitation
(Chaudhry et al., 1999 ). Approximately 20% of the transfected cells in
a field of ~30 (and no control cells) showed pH changes with the addition of 10 mM amino acid substrate. pH calibration was
performed by using buffers at various pH containing 60 mM
KCl and 5 µM nigericin. Quantitation and statistics were
performed with Prism (GraphPad Software).
Electrophysiology. Xenopus oocytes were prepared
as described previously (Quick and Lester, 1994 ); they were washed
extensively in (in mM) 96 NaCl, 2 KCl, 1 MgCl2, 5 HEPES, pH 7.4, and 1.8 CaCl2 (ND96, pH 7.4) and injected with capped
LYAAT1 cRNA transcribed from the pGEMHE plasmid (Liman et al., 1992 )
(Ambion, Austin, TX). After injection the oocytes were
stored at 14°C in ND96 containing 2.5 mM sodium
pyruvate, 0.5 mM theophylline, 5%
heat-inactivated horse serum, and 50 µg/ml gentamycin for 4-6 d
before use. Two-electrode voltage-clamp recordings were performed with
0.1-1.0 M electrodes via Geneclamp 500B (Axon
Instruments, Union City, CA) at room temperature in ND96, pH 6.5 (except where noted in the text). Oocytes were held at -30 mV and
stepped for 250 msec (with 100 msec between) from +40 to -140 mV. For
charge/flux measurements the oocytes were incubated in ND96, pH 6.5, containing 0.625 mM L-[5-3H]-proline
for 5 or 10 min, washed for 1 min, and solubilized in 100 µl of 1%
SDS; the radioactivity was measured by scintillation counting in
Ecolume. Background uptake by uninjected oocytes was subtracted from
the uptake by oocytes expressing LYAAT1 to yield specific transport.
The uptake of 3H-proline by individual
oocytes was compared with currents generated over the same time
interval in the same oocyte. Quantitation and statistics were performed
with Prism (GraphPad Software).
Antibody production. A glutathione S-transferase
(GST) fusion containing the N terminus of rat LYAAT1 from residues +1
to +45 was produced in the BL21 strain of Escherichia coli
and purified by chromatography over glutathione-agarose; ~250 µg of
the protein was inoculated into rabbits at monthly intervals, and
bleeds were performed 10-12 d after the boosts (QCB,
Hopkinton, MA).
Western blot analysis. LYAAT1 was expressed in HeLa cells
via the vaccinia virus-T7 polymerase system. Cells were harvested 20 hr
after transfection and homogenized in 0.32 M sucrose buffer and 10 mM HEPES, pH 7.4, containing 1% Triton X-100, 20 mM NH4Cl, and protease inhibitors. To
prepare brain extracts, we froze an adult male rat brain in liquid
nitrogen and homogenized it in the same buffer; the nuclei were
sedimented at 1000 × g for 10 min. The resulting HeLa
cell (10 µg) or brain extracts (30 µg) were separated by
electrophoresis through 10% acrylamide, transferred to polyvinylidene
difluoride, and immunostained as described previously (Krantz et
al., 2000 ), using the rabbit LYAAT1 antibody at 1:10,000, a goat
anti-rabbit secondary antibody conjugated to horseradish peroxidase,
and the SuperSignal West Pico chemiluminescence detection system
(Pierce, Rockford, IL).
Immunofluorescence. For immunofluorescence the HeLa cells
were transfected with the LYAAT1 cDNA in pcDNA3.1
(Invitrogen). Primary hippocampal cultures prepared from
1-d-old rats were grown for 10 d on glass coverslips coated with
poly-D-lysine. All cells were fixed in 4% paraformaldehyde
for 5 min at room temperature; 100% methanol at -20°C for 5 min;
rinsed in PBS; blocked in PBS containing 2% normal goat serum, 2%
bovine serum albumin, 1% fish skin gelatin, and 0.02% saponin; and
incubated in the same buffer with 1% normal goat serum and the LYAAT1
antibody at 1:2000 for 1 hr at room temperature or overnight at 4°C.
For double labeling in HeLa cells a mouse monoclonal CD107a antibody
(LAMP-1; PharMingen, San Diego, CA) was used at a dilution
of 1:2000. In hippocampal cultures a mouse monoclonal
antibody to LAMP1 (Stressgen Biotechnologies, San Diego,
CA) was used at 1:7500 and a mouse monoclonal antibody to synaptophysin
(p38) at 1:2000. Subsequent washes and incubations were performed at
room temperature in the same buffer lacking horse serum. Secondary
antibodies (goat anti-mouse or goat anti-rabbit) were conjugated to
either Alexa 488 or Alexa 594 fluorophores (Molecular
Probes). In the hippocampal cultures the final washes contained
1% glycine to reduce background fluorescence. The fluorescence was
examined by confocal laser microscopy.
Trypsin digestion of cultured hippocampal neurons.
Dissociated hippocampal neurons were plated onto glass coverslips
at a density of 50-100,000 per well in a 24-well plate. After 10 d in vitro the cells were rinsed twice for 10 min each in
PBS (with Ca2+ and
Mg2+) at 37°C and 5%
CO2 and were incubated for 10 min at 37°C in 100 µl of
Ca2+/Mg2+-free
PBS ± 100 µg/ml trypsin ± 1% Triton X-100. The reaction was terminated by the addition of EDTA, multiple protease inhibitors (PMSF, trypsin inhibitor, leupeptin, antipain), and SDS sample buffer
(Pierce) and by boiling for 5 min (Renick et al., 1999 ). Approximately one-third of the extract from each coverslip was subjected to electrophoresis through 4-20% acrylamide, transferred to
a nylon filter, and stained with LYAAT1 antibody at 1:10,000 or a
rabbit synaptophysin antibody at 1:5000; the deposits were visualized
with HRP-conjugated secondary antibodies and SuperSignal West Pico
chemiluminescent detection system (Pierce).
Measurement of intracellular pH in neurons. Previous studies
have shown that the green fluorescent protein (GFP) is an efficient indicator of intracellular pH (Kneen et al., 1998 ). Dissociated hippocampal cultures grown for 7 d in vitro were
transfected with the GFP cDNA under the control of the chicken actin
promoter with the use of Effectene (Qiagen, Chatsworth,
CA) and were examined 3-7 d later with a Zeiss
(Oberkochen, Germany) Pascal LSM 5 laser-scanning microscope.
Coverslips containing transfected cells were mounted in a laminar-flow
chamber and perfused with a Ringer's solution [containing (in
mM) 115 NaCl, 5.0 KCl, 1.0 MgCl2, 1.8 CaCl2, 5.0 HEPES, 5.0 glucose, pH 7.4]. In Na+-free
solutions Na+o was
replaced by equimolar amounts of
Li+o. With the use of a
488 nm argon laser under low power to avoid photobleaching and a 63×
water immersion objective (0.95 numerical aperture), GFP-expressing
cells with the characteristic morphology of pyramidal neurons were
imaged (512 × 512 pixels) every 10-15 sec. After the experiment
the regions of interest corresponding to the cell body or processes
were selected; the average intensity was computed for each. The
addition of NH4Cl at the end of experiments
produced the expected rapid alkalinization, and its removal produced
the expected acidification.
 |
Results |
To determine the distribution of LYAAT1 in the brain, we performed
in situ hybridization. The cortex, thalamus, pyramidal cell
layer of the hippocampus, and Purkinje cells of the cerebellum strongly
and specifically label for LYAAT1 mRNA (Fig.
1B-G). The absence of
hybridization to white matter, together with the labeling of specific
cell populations in hippocampus and cerebellum, suggests that
expression is restricted to neurons. However, the hybridization to
hippocampal pyramidal cells and cerebellar Purkinje cells indicates that both glutamatergic and GABAergic neurons express LYAAT1.

View larger version (123K):
[in this window]
[in a new window]
|
Figure 1.
Expression of LYAAT1 in the brain.
A, Predicted protein sequence of rat LYAAT1 aligned with
the vesicular GABA transporter (VGAT), the system N transporter SN1,
and the closely related LYAAT2. Horizontal lines over
the sequence indicate nine putative transmembrane domains (TMD
1-9), and asterisks indicate potential N-linked
glycosylation sites. B, C, In
situ hybridization for LYAAT1 in rat brain slices with the use
of antisense (B) and sense
(C) probes. Ctx, Cortex;
Cpu, caudate putamen; Hc, hippocampus;
Th, thalamus. Scale bar, 2 mm. D, E,
Dark-field microscopy of autoradiographic images from D
and E, respectively, shows strong hybridization in the
pyramidal cell layers of hippocampal fields CA1 and CA3. The granule
cell layer of the dentate gyrus (DG) expresses
lower levels. F, G, High-magnification dark-field image
of the cerebellum hybridized with antisense (F)
and sense (G) probes. Arrows
indicate the strongly hybridizing Purkinje cell layer
(Pc). Molecular (m) and granule
(g) cell layers express lower levels. The white
matter (w) shows essentially no labeling. Scale
bar: G (for E-G), 500 µm.
|
|
Neutral amino acid transport
Previous studies have shown that the overexpression of
LYAAT1 can result in cell surface expression, enabling the measurement of uptake into intact cells (Sagne et al., 2001 ). We used the vaccinia
virus-T7 polymerase system to overexpress LYAAT1 in HeLa cells and
confirmed the plasma membrane localization by immunofluorescence (data
not shown). By measuring uptake at an external pH
(pHo) of 5.5, we created conditions analogous to
efflux from acidic lysosomes. Under these conditions we observed
time-dependent, saturable uptake of
3H-proline with a
Km 870 ± 419 µM (Fig.
2A,B), similar to the
previously reported Km for GABA ~500
µM (Sagne et al., 2001 ). With the use of 2 mM amino acid to compete with the uptake of
3H-proline, GABA was the most potent
inhibitor, followed by proline, sarcosine, glycine, and alanine (Fig.
2C). Among the small neutral amino acids only serine is not
recognized by LYAAT1.

View larger version (32K):
[in this window]
[in a new window]
|
Figure 2.
Proline transport by LYAAT1. A, A
representative time course of specific 3H-proline uptake by
cells expressing LYAAT1 (minus untransfected). B,
Representative saturable uptake of proline by LYAAT1. Multiple
independent experiments indicate a Km
870 ± 419 µM; n = 9. C, Inhibition of 3H-proline uptake at 5 min
by 10 mM amino acid. GB, GABA;
sarc, sarcosine; single letters reflect
standard amino acid nomenclature. D, Ionic and energetic
dependence of proline uptake. Dissipation of pH by nigericin
(nig) reduces transport by LYAAT1 to a greater extent
than dissipation of  with valinomycin
(val). E, Proline transport by
LYAAT1 depends on low external pH
(pHo). Results are normalized
to maximal uptake at pHo 5.5. F, Replacement
of choline chloride with 60 mM KCl/60
mM NaCl (+KCl) or NaCl does not
reduce 3H-proline uptake significantly. On the other hand,
replacement with Na-gluconate (Na gluc) reduces, but
does not eliminate, transport. The results are normalized to uptake in
choline chloride. *p < 0.05 relative to control
(pHo 5.5 in E or choline in
F); **p < 0.001;
***p < 0.0001. For all experiments the error bars
indicate SEM.
|
|
To characterize the ionic coupling of amino acid transport by LYAAT1,
we focused on H+ because lysosomes
maintain an outwardly directed H+
electrochemical gradient. The proton ionophore nigericin, which dissipates the chemical component of this gradient ( pH) but leaves the electrical component ( ) intact, reduces
3H-proline uptake by ~65% (Fig.
2D), indicating the dependence of transport on pH.
Addition of the ionophore valinomycin, which specifically abolishes
 , reduces transport activity, suggesting dependence on  but
to a much lower extent (~14%). Consistent with a role for
H+ cotransport in LYAAT1 function,
increases in pHo over 6.0 reduce uptake (Fig.
2E), and the elimination of
Na+ and K+
have no significant effect (Fig. 2F). However,
substitution of Cl with gluconate
reduces transport by ~50%. Chloride thus is not required for
transport but appears to modulate LYAAT1 activity.
Electrogenic H+ cotransport
We previously have used the pH-sensitive dye BCECF to show that
the system N transporter SN1 mediates the exchange of
H+ for amino acid substrate (Chaudhry et
al., 1999 ). To assess more directly the coupling of LYAAT1 to
H+, again we have used BCECF. In these
experiments large concentrations of potential substrates are used to
drive the movement of coupled H+. The low
external pH important for the uptake of small amounts of radiolabeled
compounds therefore is not required. Ratiometric measurements in HeLa
cells expressing LYAAT1 show that 10 mM L- and
D-proline, alanine, and GABA reduce
intracellular pH (pHi) (Fig.
3A), indicating that they are
all substrates. None of these amino acids produces a significant change
in the pHi of mock-transfected HeLa cells (data
not shown), indicating the specificity of changes for LYAAT1. In
addition, serine, threonine, and other amino acids that failed to
inhibit proline uptake do not change pHi (Fig. 3B). Except for alanine, the various amino acid substrates
showed no significant difference in the magnitude of change that was produced (Fig. 3B), consistent with the equilibrium nature
of the pHi measurement and similar flux coupling
for all amino acid substrates.

View larger version (17K):
[in this window]
[in a new window]
|
Figure 3.
Transport by LYAAT1 involves H+
translocation. A, The pHi of HeLa cells
expressing LYAAT1 with the vaccinia virus-T7 polymerase system was
determined by ratiometric analysis via the pH-sensitive dye BCECF.
Amino acids (10 mM) were added to the cells for 5 min
intervals at the times indicated by the horizontal bars
above the trace. L-Proline, alanine, GABA, and
D-proline, but not serine, produce an acidification that
was not observed in cells transfected with empty vector. The
pHi was calibrated in the proton ionophore nigericin at
different pHo. B, The change in
pHi produced by different amino acids was quantitated as a
proportion of the response to proline. **p < 0.001 and ***p < 0.0001 relative to proline;
++p < 0.001 relative to alanine. Error
bars indicate SEM.
|
|
The cotransport of neutral amino acids and
H+ suggests that LYAAT1 moves net charge
and may generate currents coupled to amino acid flux. We therefore used
two-electrode voltage clamp to measure the currents produced by amino
acids in Xenopus oocytes expressing LYAAT1. The
addition of known substrates for LYAAT1 to cells injected with LYAAT1
cRNA, but not uninjected oocytes, produces concentration-dependent inward currents (Fig.
4A,B). The
EC50 for proline-induced currents is 1.65 ± 0.25 mM, which is not significantly different
from the Km for the uptake of
radiolabeled proline (870 ± 419 µM). High concentrations of sarcosine, alanine, and GABA also generate currents in oocytes expressing LYAAT1 (Fig. 4E), consistent
with their recognition as substrates. Although GABA appears to be
recognized with highest affinity, it produces only ~60% of the
current caused by proline, suggesting that GABA is transported more
slowly than proline.

View larger version (28K):
[in this window]
[in a new window]
|
Figure 4.
Transport by LYAAT1 is electrogenic.
A, Proline produces inward currents in
Xenopus oocytes injected with LYAAT1 cRNA. Increasing
concentrations of proline (in mM) added at the times
indicated by the horizontal bars above the trace cause
progressively larger currents. B, At a holding potential
of -70 mV the currents produced by proline are saturable. Normalizing
to the maximal response (Imax)
extrapolated from the data, the data reveal an EC50
1.65 ± 0.25 mM; n = 7. C, Current-voltage relationship (I-V
curve) of currents produced by 10 mM proline in a range of
pHo. D, Dependence of currents associated
with LYAAT1 on low pHo at a holding potential of -70 mV.
The currents were normalized to those observed at pHo 6.5;
n = 9. E, Currents produced by
different amino acids (10 mM) at -70 mV normalized to
those produced by proline. n = 6 for all except
glu, in which n = 3. F, Charge/flux ratio for proline transport. Oocyte
membrane potential was held at -70 mV (triangles) and
-30 mV (squares); the current produced by 0.625 mM 3H-proline was integrated over a 5 or 10 min
interval. The 3H-proline accumulated during this time was
used to calculate the amino acid uptake, and the results were fit by
linear regression to yield a slope of 0.91 ± 0.07 (r2 = 0.493). For all
experiments the error bars indicate SEM. *p < 0.05, **p < 0.001, and ***p < 0.0001 relative to pHo 6.5 (D) and
proline (E).
|
|
The currents associated with LYAAT1 exhibit a dependence on
pHo similar to the measurements of flux (Fig.
4C,D). The relationship of substrate-induced currents to
voltage also shows strong rectification: if the currents are coupled
stoichiometrically to transport, the addition of external amino acid
can generate only inward currents. To characterize the flux coupling
further, we measured the ratio of charge moved per amino acid. Fitting
the combined data at both -30 and -70 mV (Fig. 4F)
by linear regression shows a charge/flux ratio 0.91 ± 0.07 (r2 = 0.493), demonstrating
that all of the observed currents are coupled stoichiometrically to
transport and indicating a stoichiometry of 1 proton/1 amino acid.
Localization in somatic lysosomes and axonal processes
To characterize the subcellular location of LYAAT1, we raised an
antibody to the cytoplasmic N terminus expressed as a fusion protein in
bacteria. The antiserum recognizes an ~55 kDa protein in transfected
HeLa cell extracts, but not in the extracts from cells transfected with
vector alone (Fig. 5A). The
additional bands observed in untransfected membranes may represent
endogenous LYAAT1 or cross-reactivity with an unrelated protein.
However, the antibody does not recognize closely related LYAAT2
expressed in HeLa cells by transfection (Fig. 5B). In brain
extracts the antibody recognizes proteins of ~35, 40, and 90 kDa, but
adsorption with the GST fusion protein eliminates only the ~35 and 40 kDa species, indicating that recognition of the ~90 kDa form is not specific (Fig. 5C). The antibody also detects LYAAT1 by
immunofluorescence (Fig. 5D), and adsorption again
eliminates the signal (Fig.
6D). In HeLa cells the
LYAAT1 colocalizes entirely with the lysosomal protein LAMP1 (Fig.
5D), and this was observed in cells expressing low as well
as high levels of LYAAT1. Further, LYAAT1 localizes to the same
LAMP1+ compartment when expressed in PC12
and COS7 cells (data not shown). Lysosomal degradation indeed may
account for the lower molecular weight species of LYAAT1 observed from
HeLa cells and brain extracts in Western blots.

View larger version (44K):
[in this window]
[in a new window]
|
Figure 5.
LYAAT1 localizes to lysosomes. A,
Western blot analysis of extracts from HeLa cells transfected with the
LYAAT1 cDNA or empty plasmid (con) shows that the LYAAT1
antibody recognizes an ~55 kDa protein only in cells expressing
LYAAT1. B, Immunoblots of extracts from HeLa cells
transfected with the LYAAT1 and 2 cDNAs (top) indicate
that the LYAAT1 antibody ( -LYAAT1) specifically recognizes LYAAT1
and not LYAAT2. LYAAT2 protein nonetheless is detectable by using an
antibody to LYAAT2 ( -LYAAT2). C, In
brain extracts -LYAAT1 recognizes proteins of ~35, 40, and 90 kDa,
but adsorption with the GST fusion protein used to produce -LYAAT1
(GST-LYAAT1) eliminates only the two smaller species,
indicating that recognition of the ~90 kDa protein is nonspecific.
Markers on the left of A and
B indicate kilodaltons. D,
Immunofluorescence in transfected HeLa cells shows that LYAAT1
(red) colocalizes almost completely with the lysosomal
protein LAMP-1 (green).
|
|

View larger version (39K):
[in this window]
[in a new window]
|
Figure 6.
LYAAT1 localizes to axonal processes as well as
somatodendritic lysosomes. Shown is double labeling of hippocampal
neurons for LYAAT1 (A, D, G, J) and for LAMP1
(B, E), synaptophysin (syp;
H), and sec6 (K). Merged
images are shown in C, F, I, and L; all
images were visualized by confocal laser microscopy.
A-C, LYAAT1 colocalizes with LAMP1 in cell bodies
(arrows, C). However, several LAMP1+
structures do not label for LYAAT1 (arrowhead), and in
processes that generally contain little if any LAMP1 the
LYAAT1+ structures do not label for LAMP1
(asterisk). D-F, Adsorption of the
antibody with the GST-LYAAT1 fusion protein eliminates the staining for
LYAAT1. G-I, In processes the LYAAT1 shows only partial
colocalization with synaptophysin (arrowheads). Most
structures label only for LYAAT1 or synaptophysin. J-L,
The LYAAT1 in processes colocalizes extensively with exocyst subunit
sec6. However, the colocalization does not extend to cell bodies
(asterisk), which label only for LYAAT1 and not for
sec6. Scale bar in L applies to all images.
|
|
We immunostained primary hippocampal cultures to assess the
localization of LYAAT1 in neurons. Double staining with the neuronal marker MAP2 (data not shown) confirmed the localization to neurons suggested by in situ hybridization. However, LYAAT1
colocalizes with MAP2 only in cell bodies, not in dendritic processes
(data not shown). Within neuronal cell bodies, very similar to HeLa cells, LYAAT1 colocalizes extensively with LAMP1 (Fig.
6A-C, arrows), and adsorption with GST
fusion protein eliminates the signal (Fig. 6D-F). However, LYAAT1 does not colocalize
with LAMP1 at all sites. Near the cell body some membranes label only
for LAMP1 (Fig. 6C, arrowhead), and others label
only for LYAAT1 (Fig. 6C, asterisk). Further,
axonal processes contain substantial LYAAT1 but very little if any
LAMP1 (data not shown). Within axonal processes the LYAAT1 has a
punctate distribution, suggesting possible localization at synapses.
Several puncta indeed label for both LYAAT1 and the synaptic vesicle
protein synaptophysin (Fig. 6G-I, arrowheads). However, many puncta stain only for LYAAT1 or only for synaptophysin, indicating that much of the LYAAT1 in axons does not appear to reside
at synapses or even at clusters of synaptic vesicles.
Previous work has shown that a complex of proteins termed the exocyst
identifies the sites at which secretory vesicles fuse with the plasma
membrane (Finger and Novick, 1998 ; Hsu et al., 1999 ). In yeast the
exocyst acts upstream of other proteins involved in secretion, and it
marks the site of membrane addition to the growing bud early in the
cell cycle and the neck between mother and daughter cells later in the
cycle (TerBush and Novick, 1995 ; Finger et al., 1998 ). Interestingly,
the components of the exocyst do not always colocalize with synaptic
markers in neurons. In particular, the rat sec6/sec8 exocyst complex
appears at the growth cone and at periodic sites along the axon early
in development but downregulates during subsequent synapse formation
(Hazuka et al., 1999 ). Although axonal, the complex thus does not
colocalize extensively with synaptic markers, raising the possibility
that LYAAT1 might colocalize with the exocyst. To test this
possibility, we double stained 12-d-old hippocampal cultures for sec6
as well as LYAAT1 and observed extensive colocalization (Fig.
6J-L). Only the perikaryal labeling for LYAAT1 in
lysosomes does not double stain for sec6 (Fig.
6L).
Because the subcellular location of sec6 and sec8 in mammalian neurons
changes during development, we examined the colocalization of LYAAT1
with synaptophysin and sec6 in cultures grown for different times
in vitro. Figure 7 shows that
the intensity of staining for both LYAAT1 and synaptophysin increases
with days in culture. However, even at the earliest times (Fig.
7A-C) distinct structures appear to label for the two
proteins. The segregation occurs at the level of entire processes, with
some labeling predominantly if not exclusively for either LYAAT1 or
synaptophysin. To quantitate the segregation to different processes as
a function of time, we counted processes expressing only LYAAT1, both
LYAAT1 and synaptophysin, and synaptophysin alone at 4, 6, 9, and
12 d in vitro. Although the total expression of LYAAT1
increases over time, Figure
8A shows that the
number of LYAAT1-only processes declines. LYAAT1 thus may have roles in
early as well as later stages of process outgrowth and differentiation.
Nonetheless, most processes contain both proteins. Within processes
expressing both LYAAT1 and synaptophysin, however, the proteins
localize to distinct structures. Quantifying the extent of
colocalization of puncta within processes of day 12 cultures, we
observe almost equal numbers labeling for LYAAT1 alone, synaptophysin
alone, and both proteins (Fig. 8B).

View larger version (33K):
[in this window]
[in a new window]
|
Figure 7.
Double staining for LYAAT1 and synaptophysin in
hippocampal cultures at different times in vitro.
Hippocampal neurons grown for 4 (A-C), 6 (D-F), 9 (G-I), and 12 (J-L) d in vitro were
immunostained for LYAAT1 (A, D, G, J) and
synaptophysin (syp; B, E, H, K).
The immunofluorescence was detected by confocal laser microscopy;
merged images are shown in C, F, I, and
L. In general, LYAAT1 expression increases with time in
culture. At 4 d in vitro LYAAT1 and synaptophysin
appear to be segregated to different processes. Although segregation
persists at later times as well, LYAAT1 and synaptophysin progressively
localize to the same processes. Despite partial colocalization the
distribution of the two proteins within common processes generally
remains distinct. The strip beneath each
panel is magnified 4× to illustrate more clearly the
segregation within processes. The scale bar in L applies
to all main panels.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Figure 8.
Quantitation of LYAAT1 colocalization with
synaptophysin. A, In hippocampal cultures that were
double labeled for LYAAT1 and synaptophysin (syp), the
number of independent processes (originating at distinct sites
from the cell body) labeled for LYAAT1 alone, LYAAT1 and
synaptophysin (syp), or synaptophysin alone was counted
at 4, 6, 9, and 12 d in vitro and plotted as a
proportion of total processes at that time point. The percentage
of double-labeled processes increases with time in culture, and
the number of LYAAT1+-only processes declines. The
total number of processes counted at each time point was 200-300.
*p < 0.05 and ***p < 0.0001 relative to
LYAAT1+/syp+ processes.
B, At 12 d in vitro the
colocalization of LYAAT1 and synaptophysin within double-labeled
processes was quantitated by counting the number of puncta labeled for
LYAAT1 alone, LYAAT1 and synaptophysin, and synaptophysin alone. The
two proteins remain mainly segregated at this late time in culture;
300-1300 puncta were counted. Error bars indicate SEM;
n = 4.
|
|
We also examined the colocalization of LYAAT1 with sec6 as a function
of time in culture. Unlike LYAAT1 and synaptophysin, sec6 is expressed
strongly at early times, consistent with previous observations (Hazuka
et al., 1999 ). From day 6 on, however, LYAAT1 colocalizes extensively
with sec6 (Fig. 9).

View larger version (42K):
[in this window]
[in a new window]
|
Figure 9.
Colocalization of LYAAT1 with sec6 from 4 through
12 d in vitro. Hippocampal neurons grown for 4 (A-C), 6 (D-F), 9 (G-I), and 12 (J-L) d
in vitro were immunostained for LYAAT1 (A, D, G,
J) and sec6 (B, E, H, K). The
immunofluorescence was detected by confocal laser microscopy; merged
images are shown in C, F, I, and L. In
contrast to the low levels of LYAAT1 expression in day 4 cultures, sec6
already is expressed at high levels. Nonetheless, essentially all of
the LYAAT1 detected at day 4 colocalizes with sec6, and this pattern
persists through day 12. The strip beneath each main
panel is magnified 4× to illustrate the colocalization.
The scale bar in L applies to all main
panels.
|
|
Expression at the cell surface
Heterologous expression of LYAAT1 results in the
H+-dependent uptake of neutral amino acids
from the extracellular medium and hence localization to the cell
surface, but the extent to which endogenous LYAAT1 localizes to the
plasma membrane remains unclear, particularly in neurons. We therefore
used a protease protection assay to assess the amount of LYAAT1
expressed on the surface of neurons. The addition of trypsin to
dissociated hippocampal cultures results in degradation of most, but
not all, LYAAT1 in the culture (Fig.
10, top panel). As
expected, the addition of Triton X-100 results in the complete loss of
LYAAT1 by making intracellular pools available to the exogenous
protease. The amount of trypsin used was thus fully capable of
degrading all of the accessible LYAAT1. To assess the specificity of
degradation by exogenous protease, we used the synaptic vesicle protein
synaptophysin, which resides at low levels on the cell surface. Indeed,
the amount of trypsin that was used does not appear excessive because
it failed to degrade all but a small fraction of the synaptic vesicle protein synaptophysin in the absence of detergent although it could
degrade all of the synaptophysin in the presence of detergent (Fig. 10,
bottom panel).

View larger version (16K):
[in this window]
[in a new window]
|
Figure 10.
Accessibility of neuronal LYAAT1 to exogenous
protease. Neonatal rat hippocampal cultures maintained for 10 d
in vitro were treated with trypsin (100 µg/ml) in the
presence or absence of 1% Triton X-100. Treatment with trypsin
resulted in degradation of most LYAAT1 even in the absence of detergent
(top panel). In contrast, the synaptic vesicle
protein synaptophysin (syp) undergoes minimal
degradation in response to exogenous protease (bottom
panel). However, both proteins show full sensitivity to
trypsin in the presence of detergent. The arrows
indicate apparent full-length LYAAT1 and synaptophysin, and the
arrowheads indicate degradation products of LYAAT1.
Markers on the right indicate kilodaltons.
|
|
The cotransport of H+ by LYAAT1 provides
an additional way to assess cell surface expression in neurons. If
LYAAT1 resides at the plasma membrane, substrates should produce the
same changes in pHi observed in transfected HeLa
cells. To monitor pHi, we used the pH-sensitive
GFP expressed in dissociated hippocampal neurons by transfection (Kneen
et al., 1998 ). Because of the small volume of neuronal processes, the
fluorescence of GFP provides a much stronger fluorescent signal than
BCECF. Similar to HeLa cells monitored with the pH-sensitive dye BCECF,
external sarcosine reduces the pHi of hippocampal
neurons in both the cell body and processes (Fig.
11A,B). Proline also
acidifies the neurons, and, consistent with a role for LYAAT1, the
pHi shifts occur in LiCl as well as NaCl and
hence do not depend on Na+. Physiological
studies of pHi thus further support the cell
surface expression of LYAAT1 by neurons.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 11.
LYAAT1-dependent pHi changes in
neuronal cell bodies and processes. Dissociated hippocampal neurons
maintained for 7 d in vitro were transfected with a
GFP cDNA and imaged by confocal laser microscopy 3-7 d later. In both
the cell body (A) and processes
(B) 10 mM sarcosine causes
acidification. The addition of NH4Cl (15 mM)
produces the anticipated alkalinization, and its removal produces the
expected acidification. C, D, Proline (10 mM) also causes acidification in both cell body
(C) and processes (D), and
the acidification occurs in Ringer's solution, with LiCl replacing
NaCl (horizontal bars designate Li+)
as well as in NaCl.
|
|
 |
Discussion |
The functional characterization of LYAAT1 is consistent with a
role in amino acid efflux from lysosomes. Lysosomes exhibit an
outwardly directed H+ electrochemical
gradient capable of driving efflux via a mechanism that couples
substrate efflux to H+ efflux. The
dependence of amino acid uptake by LYAAT1 on low external pH indeed
suggests that H+ is cotransported with
amino acid. Other lysosomal transport activities exhibit a similar
dependence on pH (Pisoni and Thoene, 1991 ; Mancini et al., 2000 ).
However, many transporters show a sensitivity to pH without actually
translocating H+. For example, external pH
dramatically affects the system A transporters SAT1 and 2, but these
carriers do not move H+ (Albers et al.,
2001 ; Chaudhry et al., 2002a ). We now show that the addition of
substrate to cells expressing LYAAT1 decreases pHi, demonstrating that LYAAT1 mediates
H+ as well as amino acid flux. Coupling to
H+ also predicts that LYAAT1 will
transport substrates against a concentration gradient. However, the
extent of concentration depends on the stoichiometry of coupling.
Assuming that LYAAT1 transports only amino acids and
H+ and not other ions, the observed
charge/flux ratio of 1 predicts a stoichiometry of 1 H+/1 amino acid. Given this coupling
mechanism, a lysosomal pH ~5.5 will produce an effective
concentration gradient of amino acid ~100-fold higher in the
cytoplasm than in the lumen. On the other hand, transport by LYAAT1 is
also electrogenic and involves the movement of +1 net charge into the
cell for each amino acid taken up. Assuming a potential across
lysosomal membranes approximately +50 mV, similar to that across
endosomes and neurosecretory vesicles (Holz, 1979 ; Anderson and Orci,
1988 ), LYAAT1 should concentrate substrates almost 10-fold more than
predicted solely by pH, i.e., almost 1000-fold. Similar ionic
coupling has been reported recently for the mouse orthologue of LYAAT1
(Boll et al., 2002 ). However, glycine produced outward currents at
depolarizing potentials with the mouse cDNA, raising the possibility of
an uncoupled ionic conductance in addition to currents coupled
stoichiometrically to amino acid flux. In contrast, the currents
produced by proline in oocytes expressing rat LYAAT1 rectify strongly
and do not reverse. Different substrates thus may interact differently
with LYAAT1. Nonetheless, the ionic coupling observed for both rat and
mouse orthologues predicts that LYAAT1 may serve to maintain extremely low concentrations of amino acid substrates within the lumen of lysosomes.
The cotransport of H+ and amino acids by
LYAAT1 contrasts with the activity of many related amino acid
transporters. The VGAT, which defined the family of mammalian proteins
including LYAAT1, functions as a H+
exchanger rather than cotransporter (McIntire et al., 1997 ). However,
this coupling mechanism is consistent with the role of VGAT in
packaging neurotransmitter into secretory vesicles, a process that,
given the outwardly directed H+
electrochemical gradient produced by the vacuolar
H+-ATPase (Forgac, 2000 ), can be driven by
H+ exchange, but not cotransport. In
contrast, the efflux from lysosomes mediated by LYAAT1 can be driven by
H+ cotransport, but not exchange. A family
of yeast proteins related to VGAT also functions in transport across
the membrane of the vacuole (a yeast organelle equivalent to the
vertebrate lysosome) (Russnak et al., 2001 ). Interestingly, this family
includes transporters that mediate both uptake into (AVT1) and efflux
from the vacuole (AVT3, 4, and 6), and the dependence on a
H+ electrochemical gradient suggests that
closely related proteins can couple both to
H+ exchange (AVT1) or
H+ cotransport (AVT6) (Russnak et al.,
2001 ).
LYAAT1 appears to correspond most closely to lysosomal transport system
f described previously by Pisoni et al. (1987) . System f recognizes
small neutral amino acids, whereas system p, another lysosomal
transport activity, is specific for proline. However, systems f and p
are stereoselective for L-proline, whereas LYAAT1 also
recognizes D-proline. In addition, LYAAT1 has a lower
apparent affinity (Km ~900
µM) than systems f and p
(Km ~10-70
µM) (Pisoni et al., 1987 ). LYAAT1 in fact may
correspond better to previously characterized plasma membrane transport
activities than to lysosomal system f. Membrane vesicles from the
proximal tubule of the kidney exhibit
Na+-independent, but
H+-dependent, electrogenic uptake of
D-proline with an apparent affinity ~1
mM (Roigaard-Petersen et al., 1989 ). Human
intestinal Caco-2 cells also show
Na+-independent,
H+-dependent, electrogenic uptake of small
neutral L- and D-amino acids (Thwaites et al., 1993 , 1995 ; Thwaites and Stevens, 1999 ). It
remains to be determined whether LYAAT1 or a related gene such as
LYAAT2 accounts for these plasma membrane transport activities. However, the system N transporters belong to the same family of proteins defined by VGAT and also reside at the plasma membrane where
they mediate H+ exchange (Chaudhry et al.,
1999 ; Nakanishi et al., 2001 ). The detection of activity at the plasma
membrane thus raises the possibility that LYAAT1 also has a
physiological role at the cell surface. Interestingly, we have observed
that LYAAT1 localizes to more than conventional lysosomal membranes.
By immunofluorescence LYAAT1 localizes to axonal processes as well as
to the cell bodies and dendrites of hippocampal neurons in culture.
However, we did not detect the lysosomal protein LAMP-1 in axons. To
identify the axonal structures immunoreactive for LYAAT1, we first
double labeled for the synaptic vesicle protein synaptophysin and
observed only partial colocalization. In contrast, LYAAT1 colocalizes
extensively with sec6, a subunit of the exocyst. The exocyst appears to
define plasma membrane sites for the fusion of secretory vesicles
(Finger and Novick, 1998 ), but components of the exocyst downregulate
during synapse maturation (Hazuka et al., 1999 ). The exocyst apparently
marks sites that eventually develop into synapses (Hsu et al., 1999 ).
The relative lack of LYAAT1 colocalization with synaptophysin is thus
consistent with known properties of the exocyst. On the other hand,
somatodendritic LYAAT1 does not colocalize with sec6, as anticipated
from the localization to lysosomes in this region of the cell. In
addition, the level of LYAAT1 expression increases dramatically with
days in vitro, unlike sec6, which is highly expressed at
early times. The more prominent early expression of sec6 than LYAAT1
further suggests that the exocyst may recruit membranes containing
LYAAT1 to specific sites at the cell surface, which eventually release transmitter. The partial colocalization of LYAAT1 with synaptophysin indeed may reflect the role of LYAAT1-containing membranes during intermediate stages of synapse development. Consistent with this possibility, the proportion of processes containing LYAAT1, but not
synaptophysin, declines with time in culture. The presence of rare
LYAAT1+ but
synaptophysin processes even at late
times simply may reflect the formation of new processes or branching.
Importantly, lysosomes have been implicated in synapse development.
Ultrastructural studies have revealed substantial accumulation of
lysosomal membranes at the nerve terminal during early development (Rees et al., 1976 ). The lysosomal structures observed include multivesicular bodies, residual bodies, autophagosomes, and
multilamellated bodies. Synapse maturation involves clearance of these
membranes. More recent studies have confirmed that lysosome
accumulation precedes synapse maturation and have suggested a role in
synapse remodeling and elimination (Missler et al., 1993 ). However, the properties of axonal lysosomes have remained unclear. The localization of LYAAT1 to axonal membranes that do not double label for LAMP1 as
well as to somatodendritic lysosomes now suggests that axonal processes
may contain a variant of lysosomes. Interestingly, a distinct subset of
lysosomes termed "secretory lysosomes" has been shown to mediate
the release of many biologically active molecules, including histamine
from mast cells, serotonin from basophils, clotting factors from
platelets, and melanin from melanocytes (Blott and Griffiths, 2002 ). In
addition, osteoclasts digest bone by directly exposing their lysosomes
at the cell surface (Kornak et al., 2001 ). Consistent with their more
specialized function, secretory lysosomes have been reported to contain
several proteins not found in conventional lysosomes (Peters et al.,
1991 ; Medley et al., 1996 ; Iida et al., 2000 ). Nonetheless, secretory
lysosomes also contain many proteins present in conventional lysosomes
(Blott and Griffiths, 2002 ). The location of LYAAT1 in lysosomes as
well as axons thus suggests that LYAAT1 may define a novel class of secretory lysosome in neurons. Taken together with the similarity to
H+-driven epithelial transporters noted
above, colocalization with the exocyst, a protein complex involved in
exocytosis, and detection of transport activity at the plasma membrane
further suggest that LYAAT1 may have a physiological role at the cell
surface. Interestingly, a mouse protein closely related to LYAAT1
appears to localize at the cell surface, at least when tagged with GFP
(Boll et al., 2002 ). In addition, a number of the genes implicated in
neuronal ceroid lipofuscinoses, autosomal recessive disorders of
childhood referred to collectively as Batten disease (Dawson and Cho,
2000 ; Mitchison and Mole, 2001 ), encode polytopic membrane proteins with a subcellular distribution reminiscent of LYAAT1. They localize specifically to lysosomes in many cells, but in neurons they also appear in axonal processes and colocalize only partially with synaptic
vesicle markers (Jarvela et al., 1998 ; Luiro et al., 2001 ).
 |
FOOTNOTES |
Received June 22, 2002; revised Nov. 25, 2002; accepted Nov. 29, 2002.
We thank Doris Fortin, Robert Fremeau, and Haiyan Li for their
technical guidance and helpful discussions; the Giacomini and Jan labs
for oocytes; and the National Institute of Mental Health, National
Institute of Neurological Disorders and Stroke, and National Eye
Institute for support (to C.W., R.J.R., R.P.S., J.J., D.C., and
R.H.E.).
Correspondence should be addressed to Robert H. Edwards, Departments of
Neurology and Physiology, University of California San Francisco School
of Medicine, 513 Parnassus Avenue, San Francisco, CA 94143-0435. E-mail: edwards{at}itsa.ucsf.edu.
R. J. Reimer's present address: Department of Neurology and
Neurological Sciences, Stanford University School of Medicine, P211
MSLS, 1201 Welch Road, Stanford, CA 94305.
 |
References |
-
Albers A,
Broer A,
Wagner CA,
Setiawan I,
Lang PA,
Kranz EU,
Lang F,
Broer S
(2001)
Na+ transport by the neural glutamine transporter ATA1.
Pfl
gers Arch
443:92-101[Web of Science][Medline]. -
Anderson RG,
Orci L
(1988)
A view of acidic intracellular compartments.
J Cell Biol
106:539-543[Free Full Text].
-
Blott EJ,
Griffiths GM
(2002)
Secretory lysosomes.
Nat Rev Mol Cell Biol
3:122-131[Web of Science][Medline].
-
Boll M,
Foltz M,
Rubio-Aliaga I,
Kottra G,
Daniel H
(2002)
Functional characterization of two novel mammalian electrogenic proton-dependent amino acid cotransporters.
J Biol Chem
277:22966-22973[Abstract/Free Full Text].
-
Chaudhry FA,
Reimer RJ,
Krizaj D,
Barber D,
Storm-Mathisen J,
Copenhagen DR,
Edwards RH
(1999)
Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission.
Cell
99:769-780[Web of Science][Medline].
-
Chaudhry FA,
Schmitz D,
Reimer RJ,
Larsson P,
Gray AT,
Nicoll R,
Kavanaugh M,
Edwards RH
(2002a)
Glutamine uptake by neurons: interaction of protons with system A transporters.
J Neurosci
22:62-72[Abstract/Free Full Text].
-
Chaudhry FA,
Reimer RJ,
Edwards RH
(2002b)
The glutamine commute: take the N line and transfer to the A.
J Cell Biol
157:349-355[Abstract/Free Full Text].
-
Dawson G,
Cho S
(2000)
Batten's disease: clues to neuronal protein catabolism in lysosomes.
J Neurosci Res
60:133-140[Web of Science][Medline].
-
Finger FP,
Novick P
(1998)
Spatial regulation of exocytosis: lessons from yeast.
J Cell Biol
142:609-612[Free Full Text].
-
Finger FP,
Hughes TE,
Novick P
(1998)
Sec3p is a spatial landmark for polarized secretion in budding yeast.
Cell
92:559-571[Web of Science][Medline].
-
Forgac M
(2000)
Structure, mechanism, and regulation of the clathrin-coated vesicle and yeast vacuolar H+-ATPases.
J Exp Biol
203[Pt 1]:71-80[Abstract].
-
Fremeau RTJ,
Caron MG,
Blakely RD
(1992)
Molecular cloning and expression of a high affinity L-proline transporter expressed in putative glutamatergic pathways of rat brain.
Neuron
8:915-926[Web of Science][Medline].
-
Gahl WA,
Bashan N,
Tietze F,
Bernandini I,
Schulman JD
(1982)
Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis.
Science
217:1263-1265[Abstract/Free Full Text].
-
Gravel RA,
Clarke JTR,
Kaback MM,
Mahuran D,
Sandhoff K,
Suzuki K
(1995)
The GM2 gangliosidoses.
In: The metabolic and molecular bases of inherited disease (Scriver CR,
Beaudet AL,
Sly WS,
Valle D,
eds), pp 2839-2879. New York: McGraw-Hill.
-
Hazuka CD,
Foletti DL,
Hsu SC,
Kee Y,
Hopf FW,
Scheller RH
(1999)
The sec6/8 complex is located at neurite outgrowth and axonal synapse-assembly domains.
J Neurosci
19:1324-1334[Abstract/Free Full Text].
-
Holz RW
(1979)
Measurement of membrane potential of chromaffin granules by the accumulation of triphenylmethylphosphonium cation.
J Biol Chem
254:6703-6709[Free Full Text].
-
Hsu S-C,
Hazuka CD,
Foletti DL,
Scheller RH
(1999)
Targeting vesicles to specific sites on the plasma membrane: the role of the sec6/8 complex.
Trends Cell Biol
9:150-153[Web of Science][Medline].
-
Iida T,
Ohno H,
Nakaseko C,
Sakuma M,
Takeda-Ezaki M,
Arase H,
Kominami E,
Fujisawa T,
Saito T
(2000)
Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4+ T cells.
J Immunol
165:5062-5068[Abstract/Free Full Text].
-
Jarvela I,
Sainio M,
Rantamaki T,
Olkkonen VM,
Carpen O,
Peltonen L,
Jalanko A
(1998)
Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease.
Hum Mol Genet
7:85-90[Abstract/Free Full Text].
-
Kalatzis V,
Cherqui S,
Antignac C,
Gasnier B
(2001)
Cystinosin, the protein defective in cystinosis, is a H+-driven lysosomal cystine transporter.
EMBO J
20:8940-8948.
-
Kneen M,
Farinas J,
Li Y,
Verkman AS
(1998)
Green fluorescent protein as a noninvasive intracellular pH indicator.
Biophys J
74:1591-1599[Web of Science][Medline].
-
Kornak U,
Kasper D,
Bösl MR,
Kaiser E,
Schweizer M,
Schulz A,
Friedrich W,
Delling G,
Jentsch TJ
(2001)
Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.
Cell
104:205-215[Web of Science][Medline].
-
Krantz DE,
Waites C,
Oorschot V,
Liu Y,
Wilson RI,
Tan PK,
Klumperman J,
Edwards RH
(2000)
A phosphorylation site in the vesicular acetylcholine transporter regulates sorting to secretory vesicles.
J Cell Biol
149:379-395[Abstract/Free Full Text].
-
Liman ER,
Tytgat J,
Hess P
(1992)
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.
Neuron
9:861-871[Web of Science][Medline].
-
Luiro K,
Kopra O,
Lehtovirta M,
Jalanko A
(2001)
CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease.
Hum Mol Genet
10:2123-2131[Abstract/Free Full Text].
-
Mancini GM,
de Jonge HR,
Galjaard H,
Verheijen FW
(1989)
Characterization of a proton-driven carrier for sialic acid in the lysosomal membrane. Evidence for a group-specific transport system for acidic monosaccharides.
J Biol Chem
264:15247-15254[Abstract/Free Full Text].
-
Mancini GM,
Beerens CE,
Aula PP,
Verheijen FW
(1991)
Sialic acid storage diseases. A multiple lysosomal transport defect for acidic monosaccharides.
J Clin Invest
87:1329-1335.
-
Mancini GM,
Havelaar AC,
Verheijen FW
(2000)
Lysosomal transport disorders.
J Inherit Metab Dis
23:278-292[Web of Science][Medline].
-
McIntire SL,
Reimer RJ,
Schuske K,
Edwards RH,
Jorgensen EM
(1997)
Identification and characterization of the vesicular GABA transporter.
Nature
389:870-876[Medline].
-
Medley QG,
Kedersha N,
O'Brien S,
Tian Q,
Schlossman SF,
Streuli M,
Anderson P
(1996)
Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition.
Proc Natl Acad Sci USA
93:685-689[Abstract/Free Full Text].
-
Missler M,
Wolff A,
Merker HJ,
Wolff JR
(1993)
Pre- and postnatal development of the primary visual cortex of the common marmoset. II. Formation, remodeling, and elimination of synapses as overlapping processes.
J Comp Neurol
333:53-67[Web of Science][Medline].
-
Mitchison HM,
Mole SE
(2001)
Neurodegenerative disease: the neuronal ceroid lipofuscinoses (Batten disease).
Curr Opin Neurol
14:795-803[Web of Science][Medline].
-
Nakanishi T,
Kekuda R,
Fei Y-J,
Hatanaka T,
Sugawara M,
Martindale RG,
Leibach FH,
Prasad P,
Ganapathy V
(2001)
Cloning and functional characterization of a new subtype of the amino acid transport system N.
Am J Physiol Cell Physiol
281:C1757-C1768[Abstract/Free Full Text].
-
Peters PJ,
Borst J,
Oorschot V,
Fukuda M,
Krahenbuhl O,
Tschopp J,
Slot JW,
Geuze HJ
(1991)
Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes.
J Exp Med
173:1099-1109[Abstract/Free Full Text].
-
Pisoni RL,
Thoene JG
(1991)
The transport systems of mammalian lysosomes.
Biochim Biophys Acta
1071:351-373[Medline].
-
Pisoni RL,
Flickinger KS,
Thoene JG,
Christensen HN
(1987)
Characterization of carrier-mediated transport systems for small neutral amino acids in human fibroblast lysosomes.
J Biol Chem
262:6010-6017[Abstract/Free Full Text].
-
Povlock SL,
Amara SG
(1998)
Vaccinia virus-T7 RNA polymerase expression system for neurotransmitter transporters.
In: Methods in enzymology (Amara SG,
ed), pp 436-443. San Diego: Academic.
-
Quick MW,
Lester HA
(1994)
Methods for expression of excitability proteins in Xenopus oocytes.
In: Methods in neuroscience (Conn PM,
ed), pp 261-279. San Diego: Academic.
-
Rees RP,
Bunge MB,
Bunge RP
(1976)
Morphological changes in the neuritic growth cone and target neuron during synaptic junction development in culture.
J Cell Biol
68:240-263[Abstract/Free Full Text].
-
Renick SE,
Kleven DT,
Chan J,
Stenius K,
Milner TA,
Pickel VM,
Fremeau RTJ
(1999)
The mammalian brain high-affinity L-proline transporter is enriched preferentially in synaptic vesicles in a subpopulation of excitatory nerve terminals in rat forebrain.
J Neurosci
19:21-33[Abstract/Free Full Text].
-
Roigaard-Petersen H,
Jacobsen C,
Jessen H,
Mollerup S,
Sheikh MI
(1989)
Electrogenic uptake of D-imino acids by luminal membrane vesicles from rabbit kidney proximal tubule.
Biochim Biophys Acta
984:231-237[Medline].
-
Russnak R,
Konczal D,
McIntire SL
(2001)
A family of yeast proteins mediating bidirectional vacuolar amino acid transport.
J Biol Chem
276:23849-23857[Abstract/Free Full Text].
-
Sagne C,
Agulhon C,
Ravassard P,
Darmon M,
Hamon M,
El Mestikawy S,
Gasnier B,
Giros B
(2001)
Identification and characterization of a lysosomal transporter for small neutral amino acids.
Proc Natl Acad Sci USA
98:7206-7211[Abstract/Free Full Text].
-
Smith ML,
Greene AA,
Potashnik R,
Mendoza SA,
Schneider JA
(1987)
Lysosomal cystine transport. Effect of intralysosomal pH and membrane potential.
J Biol Chem
262:1244-1253[Abstract/Free Full Text].
-
TerBush DR,
Novick P
(1995)
Sec6, Sec8, and Sec15 are components of a multi-subunit complex which localizes to small bud tips in Saccharomyces cerevisiae.
J Cell Biol
130:299-312[Abstract/Free Full Text].
-
Thwaites DT,
Stevens BC
(1999)
H+-zwitterionic amino acid symport at the brush border membrane of human intestinal epithelial (Caco-2) cells.
Exp Physiol
84:275-284[Abstract].
-
Thwaites DT,
McEwan GT,
Cook MJ,
Hirst BH,
Simmons NL
(1993)
H+-coupled (Na+-independent) proline transport in human intestinal (Caco-2) epithelial cell monolayers.
FEBS Lett
333:78-82[Web of Science][Medline].
-
Thwaites DT,
McEwan GT,
Simmons NL
(1995)
The role of the proton electrochemical gradient in the transepithelial absorption of amino acids by human intestinal Caco-2 cell monolayers.
J Membr Biol
145:245-256[Web of Science][Medline].
-
Town M,
Jean G,
Cherqui S,
Attard M,
Forestier L,
Whitmore SA,
Callen DF,
Gribouval O,
Broyer M,
Bates GP,
van't Hoff W,
Antignac C
(1998)
A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis.
Nat Genet
18:319-324[Web of Science][Medline].
-
Verheijen FW,
Verbeek E,
Aula N,
Beerens CE,
Havelaar AC,
Joosse M,
Peltonen L,
Aula P,
Galjaard H,
van der Spek PJ,
Mancini GM
(1999)
A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases.
Nat Genet
23:462-465[Web of Science][Medline].
Copyright © 2003 Society for Neuroscience 0270-6474/03/2341265-11$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
A. Taranta, S. Petrini, A. Palma, L. Mannucci, M. J. Wilmer, V. De Luca, F. Diomedi-Camassei, S. Corallini, F. Bellomo, L. P. van den Heuvel, et al.
Identification and subcellular localization of a new cystinosin isoform
Am J Physiol Renal Physiol,
May 1, 2008;
294(5):
F1101 - F1108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lecaroz, M. J. Blanco-Prieto, M. A. Burrell, and C. Gamazo
Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin
J. Antimicrob. Chemother.,
September 1, 2006;
58(3):
549 - 556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Wreden, M. Wlizla, and R. J. Reimer
Varied Mechanisms Underlie the Free Sialic Acid Storage Disorders
J. Biol. Chem.,
January 14, 2005;
280(2):
1408 - 1416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Gray, L. M. Mangravite, R. P. Owen, T. J. Urban, W. Chan, E. J. Carlson, C. C. Huang, M. Kawamoto, S. J. Johns, D. Stryke, et al.
Functional and Genetic Diversity in the Concentrative Nucleoside Transporter, CNT1, in Human Populations
Mol. Pharmacol.,
March 1, 2004;
65(3):
512 - 519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Rubio-Aliaga, M. Boll, D. M. Vogt Weisenhorn, M. Foltz, G. Kottra, and H. Daniel
The Proton/Amino Acid Cotransporter PAT2 Is Expressed in Neurons with a Different Subcellular Localization than Its Paralog PAT1
J. Biol. Chem.,
January 23, 2004;
279(4):
2754 - 2760.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|